Latest Revenue Growth News

Me Today Limited delivered a 36% revenue surge to $7.96 million in FY26, cutting its EBITDA loss by 43% and locking in $1.59 million of new capital from major shareholders ahead of October warrant exercises.

Experience Co posted a modest 2% revenue rise to $129.6 million in FY26, but underlying EBITDA slipped 8% due to weather disruptions, inflationary pressures, and industrial action. The company is advancing a $65 million deal to combine its Skydive business with Inflite Group.

CTI Logistics (ASX:CLX) posted a 69% jump in net profit to $24 million for FY26, driven by robust transport volumes, logistics growth and a $74 million uplift in property valuations. The company also declared a 14 cents per share fully franked dividend.

Kalina Power (ASX:KPO) swung to a AUD 15.8 million net profit in FY2026, driven by a CAD 18 million sale of megawatt allocation, lifting its balance sheet and cash reserves sharply.

Alliance Aviation Services posted a statutory loss of $90.9 million in FY2026, driven by a $164.8 million impairment on its Fokker fleet, while underlying profit remained within guidance. The company is realigning around core FIFO operations, fleet renewal, and cost discipline, supported by a $40 million equity raise and revised Qantas wet lease terms.

Pengana Capital Group reported a statutory loss of $5.6 million for FY26 despite a 14% rise in funds under management, driven by upfront costs linked to new product launches and expanding private credit platforms.

ParagonCare’s FY26 results show modest revenue and underlying earnings growth, overshadowed by a large credit loss provision related to the Infinity Pharmacy Group debt.

Prime Financial Group Ltd grew revenue by 22% to $60.5 million in FY26, driven by acquisitions and core business expansion. However, net profit after tax fell 15%, impacted by a higher tax rate and elevated operating costs.

TALi Digital Limited (ASX: TD1) posted a 416% jump in revenue for FY26 but also recorded a $2.2 million loss driven by a $1.3 million impairment of its YCDI! intangible assets. The company is pursuing growth through AI-focused acquisitions and a $3.3 million capital raise.

Urbanise.com Limited reported 14.3% revenue growth to $15 million in FY2026, significantly narrowing its net loss to $0.9 million while advancing a NAB partnership pilot and launching AI features.

Acrux Limited reported a 46% revenue increase to $6.6 million in FY26, driven by US generic product royalties and licensing milestones, while narrowing its net loss by 90%. The company is pivoting towards developing a female testosterone therapy with encouraging Phase II data and active regulatory engagement.

Neuren Pharmaceuticals reported an 8% rise in H1 2026 revenues driven by DAYBUE royalties, but profit fell 68% due to ramped-up R&D. The company declared its first ever dividend, signalling confidence amid ongoing clinical and regulatory milestones.